Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 11, 2017
Host susceptibility to MERS-CoV infection, a retrospective cohort study of the 2015 Korean MERS outbreakJae-Hoon Ko, Hyeri Seok, Ga Eun Park, et al.Journal of Korean Medical Science|June 21, 2022
The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 YearsDongsub Kim, Haejeong Lee, Joon-Sik Choi, et al.Yonsei Medical Journal|May 30, 2020
Successful Sirolimus Treatment for Korean Patients with Activated Phosphoinositide 3-kinase δ Syndrome 1: the First Case Series in KoreaJi Man Kang, Su Kyung Kim, Dongsub Kim, et al.Infection & Chemotherapy|April 29, 2020
Interim Guidelines on Antiviral Therapy for COVID-19Sun Bean Kim, Kyungmin Huh, Jung Yeon Heo, et al.Journal of Korean Medical Science|April 1, 2025
Rapid Recovery From SARS-CoV-2 Infection Among Immunocompromised Children Despite Limited Neutralizing Antibody Response: A Virologic and Sero-Immunologic Analysis of a Single-Center CohortDoo Ri Kim, Byoung Kwon Park, Jin Yang Baek, et al.Journal of Human Immunity|May 22, 2026
Polyclonal evolution of lymphoproliferative disorders in XLP1Dan Tomomasa, Akira Nishimura, Kenichi Yoshida, et al.Journal of Korean Medical Science|June 15, 2021
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in KoreaMin Joo Choi, Won Suk Choi, Hye Seong, et al.Infection & Chemotherapy|July 3, 2021
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19Sun Bean Kim, Jimin Kim, Kyungmin Huh, et al.Journal of Korean Medical Science|August 1, 2023
Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in KoreaYoung June Choe, Eun Hwa Choi, Jong Woon Choi, et al.Human Vaccines & Immunotherapeutics|March 18, 2024
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)Alvino Maestri, Su Eun Park, Fiona Fernandes, et al.Pageof 19